What is a stock summary page? Click here for an overview.
Business Description
BioCorRx Inc
NAICS : 621498
SIC : 8093
ISIN : US09073C1062
Description
BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -18.37 | |||||
| Debt-to-Equity | -0.24 | |||||
| Debt-to-EBITDA | -0.84 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -210.52 | |||||
| Beneish M-Score | 65.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.8 | |||||
| 3-Year EBITDA Growth Rate | 15.1 | |||||
| 3-Year EPS without NRI Growth Rate | 12.2 | |||||
| 3-Year FCF Growth Rate | 18 | |||||
| 3-Year Book Growth Rate | -14.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.08 | |||||
| 9-Day RSI | 53.18 | |||||
| 14-Day RSI | 50.89 | |||||
| 3-1 Month Momentum % | -14.21 | |||||
| 6-1 Month Momentum % | 1.88 | |||||
| 12-1 Month Momentum % | -63.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.04 | |||||
| Quick Ratio | 0.04 | |||||
| Days Sales Outstanding | 117.16 | |||||
| Days Payable | 66001.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.7 | |||||
| Shareholder Yield % | -13.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.44 | |||||
| Operating Margin % | -12866.67 | |||||
| Net Margin % | -18185.19 | |||||
| FCF Margin % | -5125.93 | |||||
| ROA % | -1038.93 | |||||
| ROIC % | -152.69 | |||||
| 3-Year ROIIC % | 36.24 | |||||
| ROC (Joel Greenblatt) % | -1741.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 175.5 | |||||
| EV-to-EBIT | -2.1 | |||||
| EV-to-EBITDA | -2.21 | |||||
| EV-to-Revenue | 269.74 | |||||
| EV-to-FCF | -4.97 | |||||
| Price-to-GF-Value | 1.95 | |||||
| Price-to-Median-PS-Value | 3.9 | |||||
| Earnings Yield (Greenblatt) % | -47.62 | |||||
| FCF Yield % | -29.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BICX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioCorRx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.027 | ||
| EPS (TTM) ($) | -0.52 | ||
| Beta | 0.27 | ||
| 3-Year Sharpe Ratio | -0.8 | ||
| 3-Year Sortino Ratio | -1.02 | ||
| Volatility % | 64.2 | ||
| 14-Day RSI | 50.89 | ||
| 14-Day ATR ($) | 0.043071 | ||
| 20-Day SMA ($) | 0.326272 | ||
| 12-1 Month Momentum % | -63.37 | ||
| 52-Week Range ($) | 0.259 - 1.5 | ||
| Shares Outstanding (Mil) | 13.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioCorRx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioCorRx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioCorRx Inc Frequently Asked Questions
What is BioCorRx Inc(BICX)'s stock price today?
The current price of BICX is $0.35. The 52 week high of BICX is $1.50 and 52 week low is $0.26.
When is next earnings date of BioCorRx Inc(BICX)?
The next earnings date of BioCorRx Inc(BICX) is .
Does BioCorRx Inc(BICX) pay dividends? If so, how much?
BioCorRx Inc(BICX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers